- Definition

Term of the commercial launch of fixed dose memantine, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	adms_CollaborativeArrangementsAdditionalCommercialLaunchDescribingPeriod
Namespace Prefix:	adms_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the collaborative arrangements costs incurred related to the prosecution and litigation of intellectual property rights are reimbursable.

+ References

No definition available.

+ Details

Name:	adms_CollaborativeArrangementsCostsIncurredRelatedToProsecutionAndLitigation
Namespace Prefix:	adms_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the maximum aggregate additional cash payments receivable upon achievement of development and regulatory milestones under the collaborative arrangements.

+ References

No definition available.

+ Details

Name:	adms_CollaborativeArrangementsMaximumAggregateAdditionalCashPaymentsReceivableUponAchievementOfDevelopmentAndRegulatoryMilestones
Namespace Prefix:	adms_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Represents the amount of proceeds from upfront payment under the collaborative arrangements.

+ References

No definition available.

+ Details

Name:	adms_CollaborativeArrangementsProceedsFromUpfrontPayment
Namespace Prefix:	adms_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_LicensingAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

License Agreements (Details) - USD ($)	1 Months Ended	9 Months Ended
License Agreements (Details) - USD ($)	Nov. 30, 2012	Sep. 30, 2017	Sep. 30, 2016
License Agreements
Period describing the commercial launch of dose		15 years
License agreement
License Agreements
Upfront payment received	$ 65,000,000
Maximum total additional cash payments receivable upon achievement of certain development and regulatory milestones	$ 95,000,000
Prosecution and litigation cost		$ 0	$ 2,400,000